BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioCT - ECPv6.3.3.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioCT X-ORIGINAL-URL:https://bioct.org X-WR-CALDESC:Events for BioCT REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20200308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20201101T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20201207T140000 DTEND;TZID=America/New_York:20201207T150000 DTSTAMP:20240328T103954 CREATED:20201106T174503Z LAST-MODIFIED:20201110T155418Z UID:4130-1607349600-1607353200@bioct.org SUMMARY:Connecticut's Biopharmaceutical Industry: Research\, Innovation & COVID-19 DESCRIPTION:The second in a two-part series highlighting Connecticut’s bioscience footprint. \n\n\n\n\n\n\n\nCo-organized by BioCT\, PhRMA and the Bipartisan Bioscience Caucus\, please join us for the second in a two part series highlighting Connecticut’s bioscience footprint. \nDuring our discussion we will learn about the scientific breakthroughs that participating companies have made in the fight against the COVID-19 pandemic\, along with the impact the industry’s work has made in Connecticut. \nFeaturing presenters from Alexion\, Boehringer Ingelheim and Pfizer \nModerated by Bristol Myers Squibb URL:https://bioct.org/event/connecticuts-biopharmaceutical-industry-research-innovation-covid-19/ LOCATION:VIRTUAL END:VEVENT END:VCALENDAR